ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Vivoryon Therapeutics Nv

Vivoryon Therapeutics Nv (0R3M)

4.71
0.00
(0.00%)
Cerrado 06 Febrero 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
4.71
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
338
0.00 Rango del Día 0.00
4.71 Rango de 52 semanas 4.71
Capitalización de Mercado [m]
Precio Anterior
4.71
Precio de Apertura
-
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
3,730
Acciones en circulación
0.00
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-
turnover
-3.62M
Beneficio neto
-28.34M

Acerca de Vivoryon Therapeutics Nv

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
Sede
Halle, Deu
Fundado
-
Vivoryon Therapeutics Nv is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R3M. The last closing price for Vivoryon Therapeutics Nv was 4.71 €. Over the last year, Vivoryon Therapeutics Nv shares have traded in a share price range of 4.71 € to 4.71 €.

Vivoryon Therapeutics Nv currently has 0 shares in issue.

0R3M Últimas noticias

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1004.714.714.71384.71DE
4004.714.714.715004.71DE
12004.714.714.7137304.71DE
26004.714.714.7137874.71DE
52004.714.714.71121724.71DE
156004.714.714.7159684.71DE
260004.714.714.7142164.71DE

0R3M - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vivoryon Therapeutics Nv?
El precio actual de las acciones de Vivoryon Therapeutics Nv es 4.71 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vivoryon Therapeutics Nv?
Vivoryon Therapeutics Nv ha negociado en un rango de 4.71 € a 4.71 € durante el último año
¿Cuál es la moneda de reporte de Vivoryon Therapeutics Nv?
Vivoryon Therapeutics Nv presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Vivoryon Therapeutics Nv?
El último ingresos anual de Vivoryon Therapeutics Nv es EUR -3.62M
¿Cuál es el último beneficio anual de Vivoryon Therapeutics Nv?
El último beneficio anual de Vivoryon Therapeutics Nv es EUR -28.34M
¿Cuál es la dirección registrada de Vivoryon Therapeutics Nv?
La dirección registrada de Vivoryon Therapeutics Nv es WEINBERGWEG 22, HALLE, 06120
¿Cuál es la dirección del sitio web de Vivoryon Therapeutics Nv?
La dirección del sitio web de Vivoryon Therapeutics Nv es www.vivoryon.com
¿En qué sector industrial opera Vivoryon Therapeutics Nv?
Vivoryon Therapeutics Nv opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NTQEnteq Technologies Plc
1.80p
(38.46%)
3.27M
NOGNostrum Oil & Gas Plc
3.50p
(25.00%)
4.22k
ORCPOracle Power Plc
0.019p
(21.79%)
2.4B
SYSSysgroup Plc
23.50p
(20.51%)
416.88k
WIZZWizz Air Holdings Plc
1,498.00p
(17.86%)
2.4M
RAIRa International Group Plc
0.75p
(-88.46%)
36.71M
TRACT42 Iot Tracking Solutions Plc
2.35p
(-21.67%)
1.4M
W7LWarpaint London Plc
431.50p
(-18.89%)
3.81M
VELAVela Technologies Plc
0.005p
(-16.67%)
104.29M
SYMESupply@me Capital Plc
0.0023p
(-16.36%)
757.58M
ORCPOracle Power Plc
0.019p
(21.79%)
2.4B
NTVONativo Resources Plc
0.0017p
(0.00%)
945.01M
SYMESupply@me Capital Plc
0.0023p
(-16.36%)
757.58M
VODVodafone Group Plc
68.12p
(2.84%)
277.86M
CPAICapai Plc
0.044p
(0.00%)
233.05M
MightyX MightyX 2 minutos hace
Minutes before 1pmE.T. Apld @.91)/lumn@5.14(+3.52%)is 5.43% differential
APLD
TJG TJG 2 minutos hace
Sorry to say, but this is no longer a Know What You Own stock, its a "They dont seem to care if you own it or not" stock... .048 with a offer of 30K, which with the volume this has shown will take half a dozen trades to get thru.

I am fine waiting and I am fine with them having to g
FDCT
oilin07 oilin07 3 minutos hace
Dont miss BLLB
BLLB
Dzelle Dzelle 3 minutos hace
Complaint Against Global Arena Holding, Inc. (GAHC) – Lack of Transparency, Filing Delinquencies, and Potential Shareholder Misrepresentation

To Whom It May Concern,

I am submitting this complaint regarding Global Arena Holding, Inc. (GAHC) due to the company’s lack of
GAHC
TheKid5 TheKid5 3 minutos hace
We are alive...????
https://ih.advfn.com/stock-market/USOTC/clean-vision-qb-CLNV/stock-news/95386850/form-schedule-13g-a-statement-of-beneficial-owne
CLNV
Trooperstocks Trooperstocks 3 minutos hace
$CBDW closing on strong volume! 1606 Corp Partners with GPOPlus to Enhance AI in Distribution https://allcapresearch.com/penny-stocks/f/1606-corp-partners-with-gpoplus-to-enhance-ai-in-distribution #accumulation #OTCQB #nasdaq #AI $GPOX @CBDWInc
CBDW GPOX
Trooperstocks Trooperstocks 3 minutos hace
$CBDW closing on strong volume! 1606 Corp Partners with GPOPlus to Enhance AI in Distribution https://allcapresearch.com/penny-stocks/f/1606-corp-partners-with-gpoplus-to-enhance-ai-in-distribution #accumulation #OTCQB #nasdaq #AI $GPOX @CBDWInc
CBDW GPOX
konshe konshe 3 minutos hace
ASII is ready to move up any time soon. Strong buy at ask 0.0005 today, See 5/6 Tomorrow
ASII
jindal jindal 3 minutos hace
Nice to see a little volume. Any amount makes me smile. Cheers !!
GEGP
shoondale shoondale 3 minutos hace
$MGON one of the oldest pump and dump scams on ihub. Many years of the same bagholders raving about the next bright shiny object that never materializes.
MGON
Viking61 Viking61 3 minutos hace
Busting through to $8 Friday🚀🚀🚀
FNMA
Myth Myth 3 minutos hace
That's great Okie, and you picked a winner there !

So good to see you here....
Golfbum22 Golfbum22 4 minutos hace
How do we view this statement, anyone?

He said release but also said depends...

Also, how long until they are done with tax policy?

appreciate any helpful responses

TIA

One and done post- thank you to the mods for saving me t
FNMA
peterus peterus 4 minutos hace
lol this market is like a lotto 
HEPA
dexprs dexprs 4 minutos hace
Was added at RSI below 20.
ace65 ace65 5 minutos hace
Its getting hit...
ATWT
outlook2020 outlook2020 5 minutos hace
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"I find it humorous that anyone  style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px"thinks that they
ENZC
ColdDarkHole ColdDarkHole 5 minutos hace
Did LCP show up again and get deleted? Or are there so many you mean just in general?
NB
StockSeedGems2143 StockSeedGems2143 5 minutos hace
Nice ! 02/06/2025 13:59:58 EST 0.0248 102951 OTCBB
TMMI
ssc ssc 5 minutos hace
You have clearly demonstrated that you are a proven liar, but why are you also too cowardly to answer a simple question:

Why do you dedicate your time here to attacking those who post the truth about liar dickran and the facts about erhc?

If lying about the facts and hi
ERHE
otcsource otcsource 5 minutos hace
Company continues to take from the PUBLIC! People's hard earned money going to those who claim this one is going to be the next big ticker in the OTC! So far PR after PR and Tweet after Tweet!! and this Tickers stays in the same pattern! The Market knows this company has nothing to truly offer bu
PSRU
GLENO34 GLENO34 5 minutos hace
Not much happening today..The only signal I have had so far today is for a move the 60 min 20MA which it just about did...Two different gurus today said,,,Market is "toppy" another said Buy the Dip.. So ther eis a complete market report..No room for error..::)
https://schrts.co/XXDjBZYR
buysellrepeat buysellrepeat 5 minutos hace
Wish I could. I'm pretty heavy here already. Lol
ATWT

Su Consulta Reciente

Delayed Upgrade Clock